Contact Us

Dr. Scott Gottlieb on Novo Nodrisk’s oral diabetes drug, future of weight-loss drugs

Thought Leader: Scott Gottlieb
October 22, 2024

Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss news of Novo Nordisk’s oral diabetes drug cutting heart-related risks in patients, state of the weight-loss drugs market, and more.

Relevant posts

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

0
Speaker List
Share My List